A EUROPEAN LEADER IN PHARMACEUTICAL PRODUCTS FOR THE CENTRAL NERVOUS SYSTEM (CNS)

With a unique understanding of the CNS market for over 35 years, Neuraxpharm develops and commercializes established brands, value added medicines, generics, Consumer Healthcare products, medical cannabis, beyond-the-pill solutions (digital health and medical devices) and orphan drugs.

We are continuously striving to offer a wide range of effective, high quality and affordable CNS treatment options in Europe.

Neuraxpharm manufactures many of its pharmaceutical products at Neuraxpharm Pharmaceuticals (formerly Laboratorios Lesvi) in Spain.

NEURAXPHARM,
SPECIALIZED IN CNS
SINCE 1985

NEURAXPHARM GROUP

Neuraxpharm develops and markets CNS pharmaceuticals related to the prevention of CNS indications in Europe's main countries

B2B solutions provider dedicated to the development and manufacturing of finished dosage forms (FDFs)
MORE

BACKWARD INTEGRATION

The consolidation of all the companies within Neuraxpharm allows us to establish growth and cross-business operational synergies in strategic aspects such as R&D, manufacturing, procurement, cross-licensing and geographical expansion